Clinical Trial

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a Phase II study to determine the efficacy of SBRT to treat liver metastases in patients with Colorectal Adenocarcinoma, Carcinoma of the Anal Canal and Gastrointestinal Neuroendocrine Tumors that are not amenable to surgery. Patients should have no evidence of extra-hepatic disease or have disease that is planned to be treated with curative intent. Therefore, SBRT is being considered as a potentially curative procedure.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2014-07-08; most recent amendment 2024-12-04.
Trial Details
NCT Number NCT02185443
Lead Sponsor University of Sao Paulo
Collaborators: Instituto do Cancer do Estado de São Paulo
Conditions Liver Metastases, Colorectal Cancer, Anal Canal Cancer, Gastrointestinal Neuroendocrine Tumors
Enrollment 43 participants
Start Date 2014-05
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-09